SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006031
Filing Date
2022-04-25
Accepted
2022-04-22 19:55:24
Documents
4
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A stro-def14a-2022.htm DEF 14A 1681808
2 GRAPHIC img206141155_0.jpg GRAPHIC 6391
3 GRAPHIC img206141155_1.jpg GRAPHIC 87638
4 GRAPHIC img206141155_2.jpg GRAPHIC 79172
  Complete submission text file 0000950170-22-006031.txt   1911049
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38662 | Film No.: 22847070
SIC: 2836 Biological Products, (No Diagnostic Substances)